FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012081777> ?p ?o ?g. }

• W2012081777 abstract "Subtraction hybridization applied to a 'differentiation therapy' model of cancer employing human melanoma cells resulted in the cloning of melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24). Initial studies confirm an inverse correlation between mda-7 expression and melanoma development and progression. Forced expression of mda-7 by means of a plasmid or via a replication incompetent adenovirus (Ad.mda-7) promotes growth suppression and induces apoptosis in a broad array of human cancers. In contrast, mda-7 does not induce growth suppressive or toxic effects in normal cells. Based on structure (containing an IL-10 signature motif), secretion by cells (including subsets of T-cells) and location on chromosome 1q (in an area containing IL-10-family genes), mda-7 has now been renamed mda-7/IL-24. Studies by several laboratories have uncovered many of mda-7/IL-24's unique properties, including cancer-specific apoptosis-induction, cell cycle regulation, an ability to inhibit angiogenesis, potent 'bystander antitumor activity' and a capacity to enhance the sensitivity of tumor cells to radiation, chemotherapy and monoclonal antibody therapy. Moreover, based on its profound cancer tropism, substantiated by in vivo human xenograft studies in nude mice, mda-7/IL-24 (administered as Ad.mda-7) was evaluated in a phase I clinical trial in patients with melanomas and solid cancers. These studies document that mda-7/IL-24 is well tolerated and demonstrates evidence of significant clinical activity. In these contexts, mda-7/IL-24 represents a unique cytokine gene with potential for therapy of human cancers. The present review focuses on three unique properties of mda-7/IL-24, namely its potent 'bystander antitumor activity', ability to sensitize tumor cells to radiation, and its antiangiogenesis properties. Additionally, an overview of the phase I clinical trial is provided. These studies affirm that mda-7/IL-24 has promise for the management of diverse cancers." @default.
• W2012081777 created "2016-06-24" @default.
• W2012081777 creator A5004806592 @default.
• W2012081777 creator A5006329957 @default.
• W2012081777 creator A5014784060 @default.
• W2012081777 creator A5017719790 @default.
• W2012081777 creator A5022501910 @default.
• W2012081777 creator A5022987623 @default.
• W2012081777 creator A5023121415 @default.
• W2012081777 creator A5024548116 @default.
• W2012081777 creator A5029495254 @default.
• W2012081777 creator A5029701997 @default.
• W2012081777 creator A5031490587 @default.
• W2012081777 creator A5036159485 @default.
• W2012081777 creator A5038524442 @default.
• W2012081777 creator A5040418083 @default.
• W2012081777 creator A5042275051 @default.
• W2012081777 creator A5046995957 @default.
• W2012081777 creator A5054970347 @default.
• W2012081777 creator A5055054082 @default.
• W2012081777 creator A5059038444 @default.
• W2012081777 creator A5059781163 @default.
• W2012081777 creator A5061036144 @default.
• W2012081777 creator A5062975163 @default.
• W2012081777 creator A5064082463 @default.
• W2012081777 creator A5064312195 @default.
• W2012081777 creator A5068736204 @default.
• W2012081777 creator A5069002313 @default.
• W2012081777 creator A5069980003 @default.
• W2012081777 creator A5074535368 @default.
• W2012081777 creator A5084876833 @default.
• W2012081777 creator A5085316261 @default.
• W2012081777 creator A5091194969 @default.
• W2012081777 date "2007-11-01" @default.
• W2012081777 modified "2023-10-14" @default.
• W2012081777 title "mda-7/IL-24, novel anticancer cytokine: Focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review)" @default.
• W2012081777 cites W1548640328 @default.
• W2012081777 cites W1555670022 @default.
• W2012081777 cites W1572047430 @default.
• W2012081777 cites W1583927081 @default.
• W2012081777 cites W1585683447 @default.
• W2012081777 cites W1593130318 @default.
• W2012081777 cites W1599277155 @default.
• W2012081777 cites W17422182 @default.
• W2012081777 cites W1880400410 @default.
• W2012081777 cites W1909048318 @default.
• W2012081777 cites W1964572311 @default.
• W2012081777 cites W1964619238 @default.
• W2012081777 cites W1966523626 @default.
• W2012081777 cites W1967666165 @default.
• W2012081777 cites W1968987342 @default.
• W2012081777 cites W1969637872 @default.
• W2012081777 cites W1970847065 @default.
• W2012081777 cites W1970856195 @default.
• W2012081777 cites W1978328945 @default.
• W2012081777 cites W1978457328 @default.
• W2012081777 cites W1981486175 @default.
• W2012081777 cites W1983366532 @default.
• W2012081777 cites W1988470304 @default.
• W2012081777 cites W1989510923 @default.
• W2012081777 cites W1989513172 @default.
• W2012081777 cites W1996981135 @default.
• W2012081777 cites W1997998868 @default.
• W2012081777 cites W1998238314 @default.
• W2012081777 cites W1999569536 @default.
• W2012081777 cites W2000000541 @default.
• W2012081777 cites W2001401716 @default.
• W2012081777 cites W2004708951 @default.
• W2012081777 cites W2004832301 @default.
• W2012081777 cites W2005581733 @default.
• W2012081777 cites W2006569353 @default.
• W2012081777 cites W2008786326 @default.
• W2012081777 cites W2010579356 @default.
• W2012081777 cites W2010581370 @default.
• W2012081777 cites W2014944687 @default.
• W2012081777 cites W2015540775 @default.
• W2012081777 cites W2016241489 @default.
• W2012081777 cites W2019072035 @default.
• W2012081777 cites W2020228079 @default.
• W2012081777 cites W2021875656 @default.
• W2012081777 cites W2022315435 @default.
• W2012081777 cites W2022494582 @default.
• W2012081777 cites W2023777764 @default.
• W2012081777 cites W2025970479 @default.
• W2012081777 cites W2026711972 @default.
• W2012081777 cites W2027776572 @default.
• W2012081777 cites W2027998129 @default.
• W2012081777 cites W2028697132 @default.
• W2012081777 cites W2029245342 @default.
• W2012081777 cites W2029931954 @default.
• W2012081777 cites W2030099710 @default.
• W2012081777 cites W2031819782 @default.
• W2012081777 cites W2031900842 @default.
• W2012081777 cites W2039252608 @default.
• W2012081777 cites W2043654385 @default.
• W2012081777 cites W2044943819 @default.
• W2012081777 cites W2047959564 @default.
• W2012081777 cites W2048408428 @default.
• W2012081777 cites W2050818262 @default.
• W2012081777 cites W2054817881 @default.

• next